3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Refractory Peripheral Primitive Neuroectodermal Tumor: new trials by email Literature Review of Refractory Peripheral Primitive Neuroectodermal Tumor trials Research Report on Refractory Peripheral Primitive Neuroectodermal Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Medulloblastoma (3) · Neuroectodermal Tumors, Primitive, Peripheral (3) · Central Nervous System Neoplasms (2) · Ependymoma (2) · Glioma (2) · Hepatoblastoma (2) · Histiocytosis, Langerhans-Cell (2) · Lymphoma, Non-Hodgkin (2) · Neuroblastoma (2) · Osteosarcoma (2) · Rhabdoid Tumor (2) · Rhabdomyosarcoma (2) · Sarcoma (2) · Sarcoma, Ewing (2) · Wilms Tumor (2)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3) · Neoplasms, Neuroepithelial (3) · Neuroectodermal Tumors (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genetic Diseases, Inborn (2) · Hemic and Lymphatic Diseases (2) · Histiocytosis (2) · Immune System Diseases (2)
Bevacizumab (1) · Disulfides (1) · Immunoglobulin G (1) · Irinotecan (1) · Temozolomide (1) · palbociclib (1) · tazemetostat (1)
National Cancer Institute (NCI) (3)
Puerto Rico (3) · United States (3) · Australia (1) · Canada (1) · New Zealand (1)
Adam S Levy (1) · Rajen Mody (1) · Susan N Chi (1)
U10CA180886 (3), U10CA098543 (1)